secwatch.observer — SEC 8-K summary
======================================

Issuer:     INOVIO PHARMACEUTICALS, INC. (INO)
CIK:        0001055726
Form:       8-K
Filed at:   2024-04-17T23:59:59+00:00
Accession:  0001193125-24-099067
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Inovio priced ~$36M underwritten offering of common stock and pre-funded warrants
--------------------------------------------------------------------------------

- Priced 2,536,258 shares at $7.693/share and pre-funded warrants for 2,135,477 shares at $7.692/warrant.
- Gross proceeds ~$36M; net proceeds ~$33.2M after underwriting discounts and expenses.
- Offering led by Deep Track Capital; closes on or about April 18, 2024.
- Oppenheimer & Co. and Citizens JMP Securities acting as joint book-running managers.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1055726/000119312524099067/0001193125-24-099067-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1055726/000119312524099067/d817715d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-099067

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer